المؤلفون: Tepper, Stewart, Ashina, Messoud, Reuter, Uwe, Brandes, Jan L, Doležil, David, Silberstein, Stephen, Winner, Paul, Leonardi, Dean, Mikol, Daniel, Lenz, Robert

المصدر: Tepper , S , Ashina , M , Reuter , U , Brandes , J L , Doležil , D , Silberstein , S , Winner , P , Leonardi , D , Mikol , D & Lenz , R 2017 , ' Safety and efficacy of erenumab for preventive treatment of chronic migraine : a randomised, double-blind, placebo-controlled phase 2 trial ' , Lancet Neurology , vol. 16 , no. 6 , pp. 425-434 .

مصطلحات الفهرس: Adolescent, Adult, Antibodies, Monoclonal/administration & dosage, Chronic Disease, Double-Blind Method, Female, Humans, Injections, Subcutaneous, Male, Middle Aged, Migraine Disorders/prevention & control, Outcome Assessment (Health Care), Receptors, Calcitonin Gene-Related Peptide/immunology, Young Adult, article

URL: https://curis.ku.dk/portal/da/publications/safety-and-efficacy-of-erenumab-for-preventive-treatment-of-chronic-migraine(1ff2c295-c902-48aa-9422-44f871bfb48d).html
https://doi.org/10.1016/S1474-4422(17)30083-2